GORMAN RUPP CO — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that GORMAN RUPP CO filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue (Net Sales)
Net sales revenue — gross revenue less returns, allowances, and discounts. Used by many manufacturers and retailers as the primary top-line figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2017 | Dec 31, 2017 | $379.39M | Feb 23, 2018 |
| FY2017 | Dec 31, 2016 | $382.07M | Feb 23, 2018 |
| FY2017 | Dec 31, 2015 | $406.15M | Feb 23, 2018 |
| FY2016 | Dec 31, 2014 | $434.93M | Mar 3, 2017 |
| FY2015 | Dec 31, 2013 | $391.67M | Mar 11, 2016 |
| FY2014 | Dec 31, 2012 | $375.69M | Mar 9, 2015 |
| FY2013 | Dec 31, 2011 | $359.49M | Mar 10, 2014 |
| FY2012 | Dec 31, 2010 | $296.81M | Mar 4, 2013 |
| FY2011 | Dec 31, 2009 | $266.24M | Mar 5, 2012 |
Gross Profit
Revenue minus the cost of goods sold (COGS). Gross profit shows how much revenue remains to cover operating expenses, R&D, and administrative costs before calculating operating income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $209.15M | Mar 2, 2026 |
| FY2025 | Dec 31, 2024 | $204.33M | Mar 2, 2026 |
| FY2025 | Dec 31, 2023 | $196.25M | Mar 2, 2026 |
| FY2024 | Dec 31, 2022 | $130.94M | Mar 3, 2025 |
| FY2023 | Dec 31, 2021 | $95.90M | Feb 26, 2024 |
| FY2022 | Dec 31, 2020 | $89.56M | Mar 8, 2023 |
| FY2021 | Dec 31, 2019 | $102.68M | Feb 28, 2022 |
| FY2020 | Dec 31, 2018 | $109.92M | Mar 1, 2021 |
| FY2019 | Dec 31, 2017 | $101.21M | Mar 2, 2020 |
| FY2018 | Dec 31, 2016 | $92.53M | Mar 4, 2019 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $53.02M | Mar 2, 2026 |
| FY2025 | Dec 31, 2024 | $40.12M | Mar 2, 2026 |
| FY2025 | Dec 31, 2023 | $34.95M | Mar 2, 2026 |
| FY2024 | Dec 31, 2022 | $11.20M | Mar 3, 2025 |
| FY2023 | Dec 31, 2021 | $29.85M | Feb 26, 2024 |
| FY2022 | Dec 31, 2020 | $25.19M | Mar 8, 2023 |
| FY2021 | Dec 31, 2019 | $35.82M | Feb 28, 2022 |
| FY2020 | Dec 31, 2018 | $39.98M | Mar 1, 2021 |
| FY2019 | Dec 31, 2017 | $26.56M | Mar 2, 2020 |
| FY2018 | Dec 31, 2016 | $24.88M | Mar 4, 2019 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $95.36M | Mar 2, 2026 |
| FY2025 | Dec 31, 2024 | $91.44M | Mar 2, 2026 |
| FY2025 | Dec 31, 2023 | $87.04M | Mar 2, 2026 |
| FY2024 | Dec 31, 2022 | $40.18M | Mar 3, 2025 |
| FY2023 | Dec 31, 2021 | $39.36M | Feb 26, 2024 |
| FY2022 | Dec 31, 2020 | $35.75M | Mar 8, 2023 |
| FY2021 | Dec 31, 2019 | $43.84M | Feb 28, 2022 |
| FY2020 | Dec 31, 2018 | $50.64M | Mar 1, 2021 |
| FY2019 | Dec 31, 2017 | $41.64M | Mar 2, 2020 |
| FY2018 | Dec 31, 2016 | $36.43M | Mar 4, 2019 |
SG&A Expense
Selling, general, and administrative expenses — the overhead costs of running the business, including salaries, marketing, legal fees, and corporate office costs. Excludes COGS and R&D.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $101.42M | Mar 2, 2026 |
| FY2025 | Dec 31, 2024 | $100.51M | Mar 2, 2026 |
| FY2025 | Dec 31, 2023 | $96.66M | Mar 2, 2026 |
| FY2024 | Dec 31, 2022 | $83.12M | Mar 3, 2025 |
| FY2023 | Dec 31, 2021 | $56.00M | Feb 26, 2024 |
| FY2022 | Dec 31, 2020 | $52.71M | Mar 8, 2023 |
| FY2021 | Dec 31, 2019 | $58.84M | Feb 28, 2022 |
| FY2020 | Dec 31, 2018 | $59.28M | Mar 1, 2021 |
| FY2019 | Dec 31, 2017 | $55.47M | Mar 2, 2020 |
| FY2018 | Dec 31, 2016 | $54.29M | Mar 4, 2019 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $106.23M | Mar 2, 2026 |
| FY2025 | Dec 31, 2024 | $69.83M | Mar 2, 2026 |
| FY2025 | Dec 31, 2023 | $98.23M | Mar 2, 2026 |
| FY2024 | Dec 31, 2022 | $13.69M | Mar 3, 2025 |
| FY2023 | Dec 31, 2021 | $45.44M | Feb 26, 2024 |
| FY2022 | Dec 31, 2020 | $51.16M | Mar 8, 2023 |
| FY2021 | Dec 31, 2019 | $62.17M | Feb 28, 2022 |
| FY2020 | Dec 31, 2018 | $41.21M | Mar 1, 2021 |
| FY2019 | Dec 31, 2017 | $43.27M | Mar 2, 2020 |
| FY2018 | Dec 31, 2016 | $53.43M | Mar 4, 2019 |
Capital Expenditures (Capex)
Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2014 | Dec 31, 2014 | $13.28M | Mar 9, 2015 |
| FY2013 | Dec 31, 2013 | $21.02M | Mar 10, 2014 |
| FY2012 | Dec 31, 2012 | $16.37M | Mar 4, 2013 |
| FY2011 | Dec 31, 2011 | $11.18M | Mar 5, 2012 |
| FY2011 | Dec 31, 2010 | $8.31M | Mar 5, 2012 |
| FY2011 | Dec 31, 2009 | $38.07M | Mar 5, 2012 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $860.06M | Mar 2, 2026 |
| FY2025 | Dec 31, 2024 | $858.47M | Mar 2, 2026 |
| FY2024 | Dec 31, 2023 | $890.36M | Mar 3, 2025 |
| FY2023 | Dec 31, 2022 | $872.83M | Feb 26, 2024 |
| FY2022 | Dec 31, 2021 | $420.75M | Mar 8, 2023 |
| FY2021 | Dec 31, 2020 | $394.46M | Feb 28, 2022 |
| FY2020 | Dec 31, 2019 | $382.76M | Mar 1, 2021 |
| FY2019 | Dec 31, 2018 | $368.28M | Mar 2, 2020 |
| FY2018 | Dec 31, 2017 | $395.02M | Mar 4, 2019 |
| FY2017 | Dec 31, 2016 | $382.82M | Feb 23, 2018 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $445.33M | Mar 2, 2026 |
| FY2025 | Dec 31, 2024 | $484.67M | Mar 2, 2026 |
| FY2024 | Dec 31, 2023 | $540.90M | Mar 3, 2025 |
| FY2023 | Dec 31, 2022 | $541.64M | Feb 26, 2024 |
| FY2022 | Dec 31, 2021 | $90.78M | Mar 8, 2023 |
| FY2021 | Dec 31, 2020 | $78.94M | Feb 28, 2022 |
| FY2020 | Dec 31, 2019 | $74.88M | Mar 1, 2021 |
| FY2019 | Dec 31, 2018 | $75.15M | Mar 2, 2020 |
| FY2018 | Dec 31, 2017 | $69.52M | Mar 4, 2019 |
| FY2017 | Dec 31, 2016 | $79.93M | Feb 23, 2018 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $414.72M | Mar 2, 2026 |
| FY2025 | Dec 31, 2024 | $373.80M | Mar 2, 2026 |
| FY2025 | Dec 31, 2023 | $349.46M | Mar 2, 2026 |
| FY2025 | Dec 31, 2022 | $331.19M | Mar 2, 2026 |
| FY2024 | Dec 31, 2021 | $329.98M | Mar 3, 2025 |
| FY2023 | Dec 31, 2020 | $315.51M | Feb 26, 2024 |
| FY2022 | Dec 31, 2019 | $307.88M | Mar 8, 2023 |
| FY2021 | Dec 31, 2018 | $293.13M | Feb 28, 2022 |
| FY2020 | Dec 31, 2017 | $325.50M | Mar 1, 2021 |
| FY2019 | Dec 31, 2016 | $302.89M | Mar 2, 2020 |
Goodwill
An intangible asset representing the premium paid above fair value when acquiring another company. A large goodwill balance signals a history of acquisitions at premium prices.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $257.97M | Mar 2, 2026 |
| FY2025 | Dec 31, 2024 | $257.55M | Mar 2, 2026 |
| FY2024 | Dec 31, 2023 | $257.72M | Mar 3, 2025 |
| FY2024 | Dec 31, 2022 | $257.72M | Mar 3, 2025 |
| FY2022 | Dec 31, 2021 | $27.24M | Mar 8, 2023 |
| FY2021 | Dec 31, 2020 | $27.54M | Feb 28, 2022 |
| FY2021 | Dec 31, 2019 | $27.22M | Feb 28, 2022 |
| FY2020 | Dec 31, 2018 | $27.23M | Mar 1, 2021 |
| FY2019 | Dec 31, 2017 | $27.55M | Mar 2, 2020 |
| FY2018 | Dec 31, 2016 | $28.03M | Mar 4, 2019 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $418.50M | Mar 2, 2026 |
| FY2025 | Dec 31, 2024 | $384.76M | Mar 2, 2026 |
| FY2024 | Dec 31, 2023 | $363.53M | Mar 3, 2025 |
| FY2023 | Dec 31, 2022 | $346.66M | Feb 26, 2024 |
| FY2022 | Dec 31, 2021 | $353.37M | Mar 8, 2023 |
| FY2021 | Dec 31, 2020 | $340.10M | Feb 28, 2022 |
| FY2020 | Dec 31, 2019 | $330.18M | Mar 1, 2021 |
| FY2019 | Dec 31, 2018 | $308.91M | Mar 2, 2020 |
| FY2018 | Dec 31, 2017 | $332.38M | Mar 4, 2019 |
| FY2017 | Dec 31, 2016 | $318.04M | Feb 23, 2018 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $35.08M | Mar 2, 2026 |
| FY2025 | Dec 31, 2024 | $24.21M | Mar 2, 2026 |
| FY2024 | Dec 31, 2023 | $30.52M | Mar 3, 2025 |
| FY2023 | Dec 31, 2022 | $6.78M | Feb 26, 2024 |
| FY2022 | Dec 31, 2021 | $125.19M | Mar 8, 2023 |
| FY2021 | Dec 31, 2020 | $108.20M | Feb 28, 2022 |
| FY2020 | Dec 31, 2019 | $80.56M | Mar 1, 2021 |
| FY2019 | Dec 31, 2018 | $46.46M | Mar 2, 2020 |
| FY2019 | Dec 31, 2017 | $79.68M | Mar 2, 2020 |
| FY2019 | Dec 31, 2016 | $57.60M | Mar 2, 2020 |
Long-Term Debt
Debt obligations due more than one year from the balance sheet date — bonds, term loans, and notes payable. High long-term debt relative to equity can signal elevated financial leverage.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $307.53M | Mar 2, 2026 |
| FY2025 | Dec 31, 2024 | $366.60M | Mar 2, 2026 |
| FY2024 | Dec 31, 2023 | $404.45M | Mar 3, 2025 |
| FY2023 | Dec 31, 2022 | $436.83M | Feb 26, 2024 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 2 | Mar 2, 2026 |
| FY2025 | Dec 31, 2024 | 1 | Mar 2, 2026 |
| FY2025 | Dec 31, 2023 | 1 | Mar 2, 2026 |
| FY2024 | Dec 31, 2022 | 0 | Mar 3, 2025 |
| FY2023 | Dec 31, 2021 | 1 | Feb 26, 2024 |
| FY2022 | Dec 31, 2020 | 0 | Mar 8, 2023 |
| FY2021 | Dec 31, 2019 | 1 | Feb 28, 2022 |
| FY2020 | Dec 31, 2018 | 1 | Mar 1, 2021 |
| FY2019 | Dec 31, 2017 | 1 | Mar 2, 2020 |
| FY2018 | Dec 31, 2016 | 0 | Mar 4, 2019 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 2 | Mar 2, 2026 |
| FY2025 | Dec 31, 2024 | 1 | Mar 2, 2026 |
| FY2025 | Dec 31, 2023 | 1 | Mar 2, 2026 |
| FY2012 | Dec 31, 2012 | 1 | Mar 4, 2013 |
| FY2012 | Dec 31, 2011 | 1 | Mar 4, 2013 |
| FY2012 | Dec 31, 2010 | 1 | Mar 4, 2013 |
| FY2011 | Dec 31, 2009 | 0 | Mar 5, 2012 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 26.31M | Mar 2, 2026 |
| FY2025 | Dec 31, 2024 | 26.23M | Mar 2, 2026 |
| FY2024 | Dec 31, 2023 | 26.19M | Mar 3, 2025 |
| FY2023 | Dec 31, 2022 | 26.09M | Feb 26, 2024 |
| FY2022 | Dec 31, 2021 | 26.10M | Mar 8, 2023 |
| FY2021 | Dec 31, 2020 | 26.10M | Feb 28, 2022 |
| FY2020 | Dec 31, 2019 | 26.07M | Mar 1, 2021 |
| FY2019 | Dec 31, 2018 | 26.12M | Mar 2, 2020 |
| FY2018 | Dec 31, 2017 | 26.11M | Mar 4, 2019 |
| FY2017 | Dec 31, 2016 | 26.09M | Feb 23, 2018 |